- NEWS
CureVac COVID vaccine let-down spotlights mRNA design challenges
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 594, 483 (2021)
doi: https://doi.org/10.1038/d41586-021-01661-0
References
Sheikh, A., McMenamin, J., Taylor, R. & Robertson, C. Lancet https://doi.org/10.1016/S0140-6736(21)01358-1 (2021).
Abu-Raddad, L. J., Chemaitelly, H. & Butt, A. A. N. Engl. J. Med. https://doi.org/10.1056/NEJMc2104974 (2021).
Kremsner, P. et al. Preprint at MedRxiv https://doi.org/10.1101/2020.11.09.20228551 (2020).
Karikó, K., Buckstein, M., Ni, H. & Weissman, D. Immunity 23, 165–175 (2005).